XML 134 R118.htm IDEA: XBRL DOCUMENT v3.20.2
Quarterly Financial Data (Unaudited) (Detail) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Oct. 02, 2020
Jul. 03, 2020
Apr. 03, 2020
Jan. 03, 2020
Sep. 27, 2019
Jun. 28, 2019
Mar. 29, 2019
Dec. 28, 2018
Oct. 02, 2020
Sep. 27, 2019
Sep. 28, 2018
Quarterly Financial Information Disclosure [Abstract]                      
Total revenues $ 850.5 $ 694.3 $ 794.5 $ 828.9 $ 878.9 $ 825.8 $ 779.4 $ 741.0 $ 3,168.2 $ 3,225.1 $ 2,919.1
Gross margin 374.7 298.5 337.2 366.8 384.6 351.4 318.2 316.1 1,377.2 1,370.3 1,273.6
Net earnings (loss) 76.5 60.9 43.1 88.9 70.4 29.5 88.4 103.9 269.4 292.2 150.3
Net earnings attributable to Varian $ 76.6 $ 61.2 $ 43.2 $ 88.2 $ 70.7 $ 29.4 $ 88.6 $ 103.2 $ 269.2 $ 291.9 $ 149.9
Net earnings per share - basic (in dollars per share) $ 0.84 $ 0.67 $ 0.48 $ 0.97 $ 0.78 $ 0.32 $ 0.97 $ 1.13 $ 2.96 $ 3.21 $ 1.64
Net earnings per share - diluted (in dollars per share) $ 0.83 $ 0.67 $ 0.47 $ 0.96 $ 0.77 $ 0.32 $ 0.96 $ 1.12 $ 2.94 $ 3.18 $ 1.62
Gain on investments $ 14.8 $ 25.7                  
Litigation charges and legal costs 10.9                    
Restructuring charges   13.9             $ 18.7    
Available for sale securities, impairment charge 8.6 9.2                  
Impairment charges     $ 40.5           58.3 $ 50.6 $ 22.4
Change in amount of contingent consideration $ 18.6   $ 8.9 $ 8.8       $ 11.6 (0.3) 18.6 0.0
Gain on sale of investment       $ 22.0         41.5 23.8 0.0
Goodwill impairment charge   50.5               50.5  
Write-off of in-process research and development related to acquisition-related activities   $ 20.8             $ 0.0 $ 20.8 $ 0.0